David Egging

David Egging has extensive experience in bioanalysis and drug development, currently serving as Head of BA Strategy in the Precision Medicine Department at UCB since January 2019. Responsibilities include overseeing global scientific management groups for bioanalytical processes and managing clinical study support. Previous roles at UCB include Ad Interim Head of Development Bioanalysis and Development Sciences Lead, where David led cross-functional teams and bioanalytical strategy initiatives. Prior to UCB, David held various leadership roles at Synthon, focusing on bioanalysis for preclinical and clinical development, immunogenicity, and binding characterization. David holds a Ph.D. in Medical Sciences from Radboud University and a Master's degree in Medical Biology from K.U.N.